Could a popular antiviral supercharge the pandemic?
Where this comes from
- Record sourced from PubMed, PMID 36758089.
- Also identified by DOI 10.1126/science.adh0582.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Molnupiravir appears to be speeding SARS-CoV-2 evolution.
Medical subject headings
- Antiviral Agents
- COVID-19
- Pandemics
- SARS-CoV-2
- Hydroxylamines
- Genome, Viral